Ionis Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2007 | — | — | $138.6M |
| Dec 2008 | — | — | $224.0M |
| Jun 2009 | — | — | $215.8M |
| Sep 2009 | — | — | $149.3M |
| Dec 2009 | $355.1M | $657.2M | $105.3M |
| Mar 2010 | — | — | $98.6M |
| Jun 2010 | $344.1M | $606.4M | $46.0M |
| Sep 2010 | $322.1M | $575.9M | $100.1M |
| Dec 2010 | $305.9M | $550.5M | $70.1M |
| Mar 2011 | $278.2M | $505.9M | $86.2M |
| Jun 2011 | $317.4M | $529.6M | $85.0M |
| Sep 2011 | $319.0M | $505.8M | $55.3M |
| Dec 2011 | $313.5M | $484.9M | $65.5M |
| Mar 2012 | $319.9M | $470.8M | $56.4M |
| Jun 2012 | $318.1M | $472.4M | $85.6M |
| Sep 2012 | $315.4M | $485.7M | $84.6M |
| Dec 2012 | $362.9M | $545.7M | $124.5M |
| Mar 2013 | $351.9M | $553.0M | $107.7M |
| Jun 2013 | $387.6M | $788.7M | $296.5M |
| Sep 2013 | $480.5M | $881.9M | $256.4M |
| Dec 2013 | $468.8M | $847.2M | $160.0M |
| Mar 2014 | $460.5M | $834.6M | $161.8M |
| Jun 2014 | $450.9M | $817.8M | $94.1M |
| Sep 2014 | $449.0M | $793.8M | $73.2M |
| Dec 2014 | $698.0M | $955.8M | $143.0M |
| Mar 2015 | $679.6M | $955.4M | $148.3M |
| Jun 2015 | $675.9M | $976.3M | $119.5M |
| Sep 2015 | $742.6M | $988.0M | $126.6M |
| Dec 2015 | $747.1M | $947.9M | $128.8M |
| Mar 2016 | $717.7M | $875.8M | $93.3M |
| Jun 2016 | $699.9M | $811.1M | $112.5M |
| Sep 2016 | $703.9M | $843.6M | $84.3M |
| Dec 2016 | $812.9M | $912.5M | $84.7M |
| Mar 2017 | $882.2M | $1.08B | $114.2M |
| Jun 2017 | $875.3M | $1.09B | $133.0M |
| Sep 2017 | $854.9M | $1.25B | $159.2M |
| Dec 2017 | $957.5M | $1.32B | $129.6M |
| Mar 2018 | $912.5M | $1.30B | $227.5M |
| Jun 2018 | $1.43B | $2.25B | $805.5M |
| Sep 2018 | $1.41B | $2.25B | $479.9M |
| Dec 2018 | $1.48B | $2.67B | $278.8M |
| Mar 2019 | $1.45B | $2.84B | $375.8M |
| Jun 2019 | $1.42B | $2.88B | $272.5M |
| Sep 2019 | $1.40B | $2.89B | $247.9M |
| Dec 2019 | $1.55B | $3.23B | $683.3M |
| Mar 2020 | $1.52B | $3.09B | $486.2M |
| Jun 2020 | $1.48B | $3.08B | $530.2M |
| Sep 2020 | $1.49B | $3.10B | $633.1M |
| Dec 2020 | $1.65B | $2.39B | $397.7M |
| Mar 2021 | $1.57B | $2.25B | $414.2M |
| Jun 2021 | $1.91B | $2.50B | $565.1M |
| Sep 2021 | $1.88B | $2.41B | $633.0M |
| Dec 2021 | $1.84B | $2.61B | $869.2M |
| Mar 2022 | $1.81B | $2.52B | $542.5M |
| Jun 2022 | $1.83B | $2.46B | $521.9M |
| Sep 2022 | $1.83B | $2.42B | $315.0M |
| Dec 2022 | $1.96B | $2.53B | $276.5M |
| Mar 2023 | $2.40B | $2.89B | $309.0M |
| Jun 2023 | $2.54B | $2.97B | $424.8M |
| Sep 2023 | $2.62B | $2.93B | $352.1M |
| Dec 2023 | $2.60B | $2.99B | $399.3M |
| Mar 2024 | $2.47B | $2.76B | $348.9M |
| Jun 2024 | $2.43B | $2.69B | $294.0M |
| Sep 2024 | $2.42B | $3.08B | $334.6M |
| Dec 2024 | $2.42B | $3.00B | $242.1M |
| Mar 2025 | $2.34B | $2.81B | $264.2M |
| Jun 2025 | $2.35B | $2.99B | $297.3M |
| Sep 2025 | $2.42B | $3.03B | $338.3M |
| Dec 2025 | $3.03B | $3.52B | $372.3M |
| Mar 2026 | $2.96B | $3.45B | $173.4M |
| Jun 2026 | $2.55B | $2.99B | $350.1M |